BIOMAT Database Logo BIOMAT Database Logo

Effects of arachidonic acid metabolites and interleukin-1 on platelet activating factor production by hepatic sinusoidal endothelial cells from mice. 1991

Y Mizoguchi, and Y Ichikawa, and K Kioka, and N Kawada, and K Kobayashi, and S Yamamoto
Third Department of Internal Medicine, Osaka City University Medical School, Japan.

The effects of interleukin-1 (IL-1) and arachidonic acid metabolites, prostaglandin (PG) E1, leukotriene (LT) B4 and LTC4, on the amount of platelet activating factor (PAF) produced and released by mouse hepatic sinusoidal endothelial cells were investigated. When hepatic sinusoidal endothelial cells were incubated with 1 microgram/mL of calcium ionophore (CaI) A23187, PAF production increased until 20 min after the start of incubation, but when the cells were incubated with PGE1 and CaI A23187, PAF production was significantly suppressed. On the other hand, when hepatic sinusoidal endothelial cells were incubated with IL-1 beta, LTB4 or LTC4 alone, PAF production significantly increased compared with that of the cells incubated without these substances. However, when the cells were incubated with PGE1 alone or with IL-1 beta, LTB4 or LTC4 and CaI A23187, these effects were not observed. These results indicated that PAF produced by hepatic sinusoidal endothelial cells is affected by IL-1 and arachidonic acid metabolites, suggesting that immune and inflammatory reactions in these cells may be regulated by chemical mediators produced by the cells themselves.

UI MeSH Term Description Entries
D007375 Interleukin-1 A soluble factor produced by MONOCYTES; MACROPHAGES, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. Interleukin-1 is a general term refers to either of the two distinct proteins, INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The biological effects of IL-1 include the ability to replace macrophage requirements for T-cell activation. IL-1,Lymphocyte-Activating Factor,Epidermal Cell Derived Thymocyte-Activating Factor,Interleukin I,Macrophage Cell Factor,T Helper Factor,Epidermal Cell Derived Thymocyte Activating Factor,Interleukin 1,Lymphocyte Activating Factor
D007975 Leukotriene B4 The major metabolite in neutrophil polymorphonuclear leukocytes. It stimulates polymorphonuclear cell function (degranulation, formation of oxygen-centered free radicals, arachidonic acid release, and metabolism). (From Dictionary of Prostaglandins and Related Compounds, 1990) 5,12-HETE,5,12-diHETE,LTB4,Leukotriene B,Leukotriene B-4,Leukotrienes B,5,12 HETE,5,12 diHETE,B-4, Leukotriene,Leukotriene B 4
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D010972 Platelet Activating Factor A phospholipid derivative formed by PLATELETS; BASOPHILS; NEUTROPHILS; MONOCYTES; and MACROPHAGES. It is a potent platelet aggregating agent and inducer of systemic anaphylactic symptoms, including HYPOTENSION; THROMBOCYTOPENIA; NEUTROPENIA; and BRONCHOCONSTRICTION. AGEPC,Acetyl Glyceryl Ether Phosphorylcholine,PAF-Acether,Phosphorylcholine, Acetyl Glyceryl Ether,1-Alkyl-2-acetyl-sn-glycerophosphocholine,Platelet Aggregating Factor,Platelet Aggregation Enhancing Factor,Platelet-Activating Substance,Thrombocyte Aggregating Activity,1 Alkyl 2 acetyl sn glycerophosphocholine,Aggregating Factor, Platelet,Factor, Platelet Activating,PAF Acether,Platelet Activating Substance
D002196 Capillaries The minute vessels that connect arterioles and venules. Capillary Beds,Sinusoidal Beds,Sinusoids,Bed, Sinusoidal,Beds, Sinusoidal,Capillary,Capillary Bed,Sinusoid,Sinusoidal Bed
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004730 Endothelium, Vascular Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components. Capillary Endothelium,Vascular Endothelium,Capillary Endotheliums,Endothelium, Capillary,Endotheliums, Capillary,Endotheliums, Vascular,Vascular Endotheliums
D000001 Calcimycin An ionophorous, polyether antibiotic from Streptomyces chartreusensis. It binds and transports CALCIUM and other divalent cations across membranes and uncouples oxidative phosphorylation while inhibiting ATPase of rat liver mitochondria. The substance is used mostly as a biochemical tool to study the role of divalent cations in various biological systems. 4-Benzoxazolecarboxylic acid, 5-(methylamino)-2-((3,9,11-trimethyl-8-(1-methyl-2-oxo-2-(1H-pyrrol-2-yl)ethyl)-1,7-dioxaspiro(5.5)undec-2-yl)methyl)-, (6S-(6alpha(2S*,3S*),8beta(R*),9beta,11alpha))-,A-23187,A23187,Antibiotic A23187,A 23187,A23187, Antibiotic
D000527 Alprostadil A potent vasodilator agent that increases peripheral blood flow. PGE1,Prostaglandin E1,Caverject,Edex,Lipo-PGE1,Minprog,Muse,PGE1alpha,Prostaglandin E1alpha,Prostavasin,Prostin VR,Prostine VR,Sugiran,Vasaprostan,Viridal,Lipo PGE1

Related Publications

Y Mizoguchi, and Y Ichikawa, and K Kioka, and N Kawada, and K Kobayashi, and S Yamamoto
Interleukin 1 stimulates platelet activating factor production in cultured human endothelial cells.
August 1986, Pharmacological research communications,
Y Mizoguchi, and Y Ichikawa, and K Kioka, and N Kawada, and K Kobayashi, and S Yamamoto
Interleukin 1 stimulates platelet-activating factor production in cultured human endothelial cells.
June 1986, The Journal of clinical investigation,
Y Mizoguchi, and Y Ichikawa, and K Kioka, and N Kawada, and K Kobayashi, and S Yamamoto
Arachidonic acid metabolites regulate interleukin-1 production.
April 1985, Biochemical and biophysical research communications,
Y Mizoguchi, and Y Ichikawa, and K Kioka, and N Kawada, and K Kobayashi, and S Yamamoto
Platelet-activating factor and arachidonic acid metabolites in psoriatic inflammation.
June 1996, The British journal of dermatology,
Y Mizoguchi, and Y Ichikawa, and K Kioka, and N Kawada, and K Kobayashi, and S Yamamoto
Production of platelet-activating factor by endothelial cells.
October 1987, Seminars in thrombosis and hemostasis,
Y Mizoguchi, and Y Ichikawa, and K Kioka, and N Kawada, and K Kobayashi, and S Yamamoto
Platelet-activating factor activates cardiac GK via arachidonic acid metabolites.
September 1991, FEBS letters,
Y Mizoguchi, and Y Ichikawa, and K Kioka, and N Kawada, and K Kobayashi, and S Yamamoto
Production of arachidonic acid metabolites by endothelial cells in hyperoxia.
August 1986, Journal of applied physiology (Bethesda, Md. : 1985),
Y Mizoguchi, and Y Ichikawa, and K Kioka, and N Kawada, and K Kobayashi, and S Yamamoto
Release of platelet-activating factor (PAF-acether) and arachidonic acid metabolites from alveolar macrophages.
December 1981, Agents and actions,
Y Mizoguchi, and Y Ichikawa, and K Kioka, and N Kawada, and K Kobayashi, and S Yamamoto
Stimulation of platelet-activating factor synthesis by a nonmetabolizable bioactive analog of platelet-activating factor and influence of arachidonic acid metabolites.
March 1989, The Journal of biological chemistry,
Y Mizoguchi, and Y Ichikawa, and K Kioka, and N Kawada, and K Kobayashi, and S Yamamoto
Platelet-activating factor-stimulated hepatic glycogenolysis is not mediated through cyclooxygenase-derived metabolites of arachidonic acid.
July 1989, The Journal of biological chemistry,
Copied contents to your clipboard!